Broker Tips
Broker tips: Indivior, Rolls Royce, ABF
Indivior is likely to gain approval from US regulators for its monthly treatment for opioid addiction, which should eventually lift company sales north of $1bn, said Citigroup on Wednesday as it upgraded the stock to 'buy' from 'neutral'.
Indivior a 'buy' for Citi on likely monthly opioid launch
Indivior is likely to gain approval from US regulators for its monthly treatment for opioid addiction, which should eventually lift company sales north of $1bn, said Citigroup on Wednesday as it upgraded the stock to 'buy' from 'neutral'.
Barclays stays at 'underweight' on Rolls Royce
Analysts at Barclays have hiked their target price for shares of Rolls Royce but take issue with the current 5% free cash flow yield the stock is trading on, telling clients the market is using a peak level to calculate the company's future cash flows as a reference.
Wednesday broker round-up
AB Foods: Goldman Sachs downgrades to Neutral with a target price of 3400p.
Goldman downgrades AB Foods on sugar prices, slower Primark growth
Associated British Foods shares offer limited upside as profits will be dulled by lower European Union sugar prices, said Goldman Sachs as it downgraded its recommendation to 'neutral' from 'buy'.
Mondi boosted by Morgan Stanley upgrade to 'overweight'
Paper and packaging group Mondi got a boost on Wednesday as Morgan Stanley upgraded the stock to ‘overweight’ from ‘equalweight’ and lifted the price target to 2,200p from 2,000p.